Reported Reactions

Devices › Device types

FDA product code MAE · class 3 · Unknown

Occluder, patent ductus, arteriosus: medical device reports filed with FDA

1,091 reports carry this product code, 2001–2026; 7 brands with a page.

1,091
reports with this product code
0% of all MAUDE reports
202
reports, 12 months to August 2026
147 in the 12 months before
33.5%
classified as malfunction
62.3% across all reports
5.7%
classified as death, as reported
0.9% across all reports

Product code MAE is FDA's classification for "Occluder, patent ductus, arteriosus" (unknown panel), a class 3 device. 1,091 medical device reports carry this product code, 0% of the MAUDE database, from April 2001 to August 2026.

202 reports arrived in the 12 months to August 2026, up 37% from 147 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (60.6%), malfunction (33.5%) and death (5.7%). 7 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Amplatzer Duct Occluder496832.1%40.4%
Amplatzer Piccolo2205613.6%19.1%
Amplatzer Septal Occluder54062.4%43.4%
Amplatzer Cribriform Occluder100.4%37.3%
Amplatzer PFO Occluder1422.8%45.7%
Ipump Pain Management System100.5%97.5%
Malleable Penile Prosthesis100%0.7%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Aga Medical34932%
Abbott Medical686.2%
Abbott Laboratories10.1%
Baxter Healthcare Pte10.1%

Reports by month, five years

01427Sep 2021: 4Oct 2021: 11Nov 2021: 7Dec 2021: 42022Jan 2022: 4Feb 2022: 8Mar 2022: 6Apr 2022: 9May 2022: 7Jun 2022: 5Jul 2022: 9Aug 2022: 4Sep 2022: 6Oct 2022: 5Nov 2022: 10Dec 2022: 72023Jan 2023: 6Feb 2023: 10Mar 2023: 12Apr 2023: 9May 2023: 14Jun 2023: 11Jul 2023: 4Aug 2023: 27Sep 2023: 4Oct 2023: 12Nov 2023: 7Dec 2023: 112024Jan 2024: 7Feb 2024: 16Mar 2024: 10Apr 2024: 7May 2024: 14Jun 2024: 9Jul 2024: 8Aug 2024: 8Sep 2024: 6Oct 2024: 13Nov 2024: 11Dec 2024: 82025Jan 2025: 12Feb 2025: 14Mar 2025: 11Apr 2025: 10May 2025: 8Jun 2025: 19Jul 2025: 16Aug 2025: 19Sep 2025: 21Oct 2025: 11Nov 2025: 14Dec 2025: 252026Jan 2026: 22Feb 2026: 13Mar 2026: 23Apr 2026: 12May 2026: 13Jun 2026: 19Jul 2026: 11Aug 2026: 18

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death5.7%62
Injury60.6%661
Malfunction33.5%366
Other0%0
Not given0.2%2

Who filed

Manufacturer report97.4%1,063
Voluntary report1.2%13
User facility report0%0
Distributor report0%0
Not given1.4%15

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Migration or expulsion of device37634.5%
Difficult to fold, unfold or collapse21019.2%
Patient device interaction problem958.7%
Off-label use716.5%
Improper or incorrect procedure or method575.2%
Material deformation524.8%
Unintended movement433.9%
Malposition of device282.6%
Inadequacy of device shape and/or size272.5%
Device dislodged or dislocated211.9%
Migrationthe device moved from where it was placed201.8%
Obstruction of flow191.7%
Patient-device incompatibilitythe device did not suit the patient171.6%
Insufficient device problem information141.3%
Difficult to removethe device was hard to remove121.1%
Premature separation121.1%
Human-device interface problem111%
Biocompatibility90.8%
Activation, positioning or separation problem80.7%
Device operates differently than expectedthe device behaved unexpectedly80.7%

Questions about occluder, patent ductus, arteriosus reports

What is product code MAE?

FDA's classification code for "Occluder, patent ductus, arteriosus", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.

How many reports carry this code?

1,091 reports through August 2026, 202 of them in the latest 12 months.

Which brands appear most often?

Amplatzer Duct Occluder (496), Amplatzer Piccolo (220), Amplatzer Septal Occluder (5), Amplatzer Cribriform Occluder (1) and Amplatzer PFO Occluder (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.